Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lion Bioscience acquires NetGenics

Executive Summary

Lion Bioscience (information management software for life sciences research and development) has acquired privately owned US-based bioinformatics company NetGenics. Lion issued 1.1mm shares of its stock in exchange for all of NetGenics' equity for a value of approximately $16.3mm (based on the average market price of Lion stock). The stock will be subject to a lock-up restriction for 180 days following the acquisition.
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies